: Question 8 Not yet answered Marked out of 1.5 P Flag question JC is a 68-year-old 165 cm Caucasian woman weighing 63 kg admitted to the hospital for elective total knee replacement surgery. Her past medical history includes anxiety and hypertension. Her other prescription medications include lisinopril 20 mg daily and paroxetine 20 mg daily. Preoperative labs include: WBC 8.6 x 103/mm3, Hct 46.0, Hgb 14.0 g/dL, Platelets 240,000/mm3, Na 134 mEq/L (mmol/), K 4.9 mEq/L (mmol/L), CI 101 mEq/L (mmol/L), CO2 22 mEq/L (mmol/L), BUN 28 mg/dL (10.0 mmol/L), scr 1.1 mg/dl (97 umol/L). Which of the following is the best recommendation for pharmacological VTE prophylaxis to reduce JC’s VTE risk following her knee replacement surgery? Select one: O Enoxaparin 30 mg subcutaneously BID Betrixaban 160 mg PO followed by 80 mg QD Rivaroxaban 15 mg PO daily O Edoxaban 30 mg PO QD